HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of Lambert-Eaton syndrome with 3,4- diaminopyridine and pyridostigmine].

AuthorsA Yachachi Monfort, F Cortés Pastor, A de la Rubia Nieto, M J Sánchez Garre
JournalFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (Farm Hosp) 2007 Jul-Aug Vol. 31 Issue 4 Pg. 254-6 ISSN: 1130-6343 [Print] Spain
Vernacular TitleTratamiento del síndrome de Lambert-Eaton con 3,4-diaminopiridina y piridostigmina.
PMID18052623 (Publication Type: Case Reports, Letter)
Chemical References
  • Cholinesterase Inhibitors
  • Potassium Channel Blockers
  • 4-Aminopyridine
  • Pyridostigmine Bromide
  • Amifampridine
Topics
  • 4-Aminopyridine (analogs & derivatives, therapeutic use)
  • Adult
  • Amifampridine
  • Cholinesterase Inhibitors (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lambert-Eaton Myasthenic Syndrome (drug therapy)
  • Potassium Channel Blockers (therapeutic use)
  • Pyridostigmine Bromide (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: